Q3 and In-vitro Bioequivalence

  • Home
  • Q3 and In-vitro Bioequivalence

Expertise in In-Vitro Studies and Q3 Characterization
We specialize in conducting in-vitro studies and Q3 characterization for various semi-solid dosage forms, including ophthalmic and otic preparations. Our studies adhere to product-specific guidance and regulatory guidelines.

State-of-the-Art Laboratory Facilities
Our analytical and formulation laboratories are well-equipped to perform:

– In-Vitro Release Testing (IVRT)
– Dissolution studies

Comprehensive Physicochemical and Structural Characterization
We provide complete Q3 characterization of topical drug products, including:

– Comparative evaluation of generic and reference products
– Assessment of sameness, similarity, and difference as per regulatory guidance

– Experienced Team of Scientists
Our dedicated team of scientists has extensive experience in managing multiple projects, including:

– Development and validation of in-vitro and Q3 characterization studies
– Addressing regulatory queries from agencies

Comparative Study Parameters

Description and Packaging 
Finish dosage form description
Packaging configuration comparison

Physical Properties 
Viscosity/Rheology
Specific Gravity
Hardness
Friability
Disintegration Time (DT)
Globule Size
Melting Range
Penetrability
Folding Endurance
Elongation
Breaking Force

Morphological Properties 
Particle Size Distribution (PSD)

In-Vitro Study 

Comparative in-vitro study

Dissolution USP Type I, II & IV

Chemical Properties 
Potency
Nuclear Magnetic Resonance (NMR)
Mass Spectrometry
Polymorphic Form

These parameters provide a comprehensive framework for comparing the test product with reference products, covering physical, chemical, and in-vitro aspects.